INSPIRE MEDICAL SYSTEMS, INC. Financials Inspire Medical Systems, Inc.
Equities
INSP
US4577301090
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 167.8 USD | -3.75% |
|
-32.79% | -17.50% |
| May. 08 | Top Premarket Decliners | MT |
| May. 07 | Transcript : Inspire Medical Systems, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,737 | 5,066 | 6,294 | 7,277 | 6,006 | 4,986 | - | - |
| Enterprise Value (EV) 1 | 1,737 | 4,857 | 6,105 | 6,826 | 5,546 | 4,546 | 4,443 | 4,285 |
| P/E ratio | -53 x | -85.9 x | -149 x | -157 x | -283 x | 1,021 x | 194 x | 70.8 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 21.2 x | 43.9 x | 27 x | 17.8 x | 9.61 x | 6.33 x | 5.24 x | 4.37 x |
| EV / Revenue | 21.2 x | 42.1 x | 26.2 x | 16.7 x | 8.88 x | 5.77 x | 4.67 x | 3.76 x |
| EV / EBITDA | -61.6 x | -114 x | -158 x | 1,095 x | 123 x | 50.7 x | 32 x | 25.3 x |
| EV / FCF | -48.8 x | -87.5 x | -246 x | 2,760 x | 5,416 x | 46.4 x | 48.1 x | 31.9 x |
| FCF Yield | -2.05% | -1.14% | -0.41% | 0.04% | 0.02% | 2.16% | 2.08% | 3.14% |
| Price to Book | 12.8 x | 21.3 x | 27.4 x | - | 10.5 x | 6.15 x | 5.23 x | 4.28 x |
| Nbr of stocks (in thousands) | 23,402 | 26,935 | 27,358 | 28,892 | 29,524 | 29,711 | - | - |
| Reference price 2 | 74.21 | 188.1 | 230.1 | 251.9 | 203.4 | 167.8 | 167.8 | 167.8 |
| Announcement Date | 2/25/20 | 2/23/21 | 2/8/22 | 2/7/23 | 2/6/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 82.05 | 115.4 | 233.4 | 407.9 | 624.8 | 788 | 951 | 1,140 |
| EBITDA 1 | -28.2 | -42.55 | -38.63 | 6.236 | 45.04 | 89.65 | 138.8 | 169.4 |
| EBIT 1 | -34.9 | -56.21 | -39.85 | -47.59 | -40.27 | -14.92 | 12.5 | 66.65 |
| Operating Margin | -42.53% | -48.72% | -17.07% | -11.67% | -6.45% | -1.89% | 1.31% | 5.85% |
| Earnings before Tax (EBT) 1 | -33.2 | -57.09 | -41.97 | -44.27 | -19.91 | 7.658 | 32.24 | 92.09 |
| Net income 1 | -33.24 | -57.2 | -42.04 | -44.88 | -21.15 | 5.121 | 27 | 75.15 |
| Net margin | -40.52% | -49.58% | -18.01% | -11% | -3.39% | 0.65% | 2.84% | 6.59% |
| EPS 2 | -1.400 | -2.190 | -1.540 | -1.600 | -0.7200 | 0.1644 | 0.8663 | 2.371 |
| Free Cash Flow 1 | -35.58 | -55.5 | -24.79 | 2.473 | 1.024 | 98 | 92.38 | 134.5 |
| FCF margin | -43.37% | -48.1% | -10.62% | 0.61% | 0.16% | 12.44% | 9.71% | 11.8% |
| FCF Conversion (EBITDA) | - | - | - | 39.66% | 2.27% | 109.31% | 66.55% | 79.39% |
| FCF Conversion (Net income) | - | - | - | - | - | 1,913.73% | 342.11% | 178.92% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 2/25/20 | 2/23/21 | 2/8/22 | 2/7/23 | 2/6/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 78.4 | 69.38 | 91.39 | 109.2 | 137.9 | 127.9 | 151.1 | 153.3 | 192.5 | 164 | 186 | 197.5 | 240.5 | 202.3 | 228.3 |
| EBITDA 1 | -1.477 | -15.7 | -0.931 | -2.092 | 15.24 | -0.68 | 5.627 | 1.895 | 32.96 | - | 14.73 | 19.89 | 44.03 | 15.3 | 23.55 |
| EBIT 1 | -1.821 | -16.06 | -14.01 | -17.19 | -0.335 | -19.5 | -16.6 | -13.47 | 9.297 | -15.22 | -10.16 | -5.235 | 15.94 | -10.93 | -0.5627 |
| Operating Margin | -2.32% | -23.14% | -15.33% | -15.75% | -0.24% | -15.25% | -10.99% | -8.79% | 4.83% | -9.28% | -5.46% | -2.65% | 6.63% | -5.4% | -0.25% |
| Earnings before Tax (EBT) 1 | -2.371 | -16.59 | -14.35 | -16.6 | 3.275 | -15.21 | -11.74 | -8.2 | 15.24 | -9.355 | -4.692 | 0.4413 | 21.35 | -4.529 | 5.562 |
| Net income 1 | -2.391 | -16.69 | -14.49 | -16.85 | 3.15 | -15.42 | -11.95 | -8.54 | 14.76 | -10 | -4.476 | 0.0923 | 19.53 | -7.071 | 4.354 |
| Net margin | -3.05% | -24.06% | -15.86% | -15.43% | 2.28% | -12.06% | -7.91% | -5.57% | 7.67% | -6.1% | -2.41% | 0.05% | 8.12% | -3.5% | 1.91% |
| EPS 2 | -0.0900 | -0.6100 | -0.5300 | -0.6000 | 0.1000 | -0.5300 | -0.4100 | -0.2900 | 0.4900 | -0.3400 | -0.1522 | 0.003210 | 0.6349 | -0.2394 | 0.0922 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/8/22 | 5/3/22 | 8/2/22 | 11/1/22 | 2/7/23 | 5/2/23 | 8/1/23 | 11/7/23 | 2/6/24 | 5/7/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 210 | 189 | 451 | 460 | 440 | 543 | 702 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -35.6 | -55.5 | -24.8 | 2.47 | 1.02 | 98 | 92.4 | 134 |
| ROE (net income / shareholders' equity) | -21.9% | -31% | -18.3% | -12.4% | -3.96% | 0.77% | 3.08% | 6.38% |
| ROA (Net income/ Total Assets) | - | -24.7% | -14.6% | -10.4% | -3.41% | 0.6% | 1.9% | 3.6% |
| Assets 1 | - | 231.2 | 288.1 | 430 | 620.9 | 853.5 | 1,421 | 2,088 |
| Book Value Per Share 2 | 5.800 | 8.810 | 8.400 | - | 19.40 | 27.30 | 32.10 | 39.20 |
| Cash Flow per Share 2 | -1.380 | -2.030 | - | 0.4100 | 0.8400 | 2.570 | 3.820 | - |
| Capex 1 | 2.74 | 2.46 | 4.67 | 9.1 | 23.6 | 24 | 28.8 | 39.1 |
| Capex / Sales | 3.34% | 2.13% | 2% | 2.23% | 3.78% | 3.04% | 3.02% | 3.43% |
| Announcement Date | 2/25/20 | 2/23/21 | 2/8/22 | 2/7/23 | 2/6/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
167.8
USD
Average target price
250.7
USD
Spread / Average Target
+49.40%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -17.50% | 4.99B | |
| +10.39% | 126B | |
| -6.86% | 10.96B | |
| +2.52% | 8.97B | |
| +38.96% | 5.56B | |
| +8.36% | 3.44B | |
| -8.84% | 2.8B | |
| -7.52% | 2.18B | |
| -3.00% | 2.16B | |
| -21.88% | 1.82B |
- Stock Market
- Equities
- INSP Stock
- Financials Inspire Medical Systems, Inc.